Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Common and Dissociable Effects of Oxytocin and Lorazepam on the Neurocircuitry of Fear - an Ultra-high Field Imaging Study

NCT03829839 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT03829839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Common and Dissociable Effects of Oxytocin and Lorazepam on the Neurocircuitry of Fear - an Ultra-high Field Imaging Study
Lead sponsor
University Hospital, Bonn
Phase
Phase 1
Overall status
Completed
Start date
March 3, 2016
Completion date
August 16, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxytocin, lorazepam, anti-anxiety agents, physiological effects of drugs